Three major hospitals in Pune implement SoftLink's HIS
For more than a decade SoftLink International has been developing cutting-edge products in the field of healthcare IT and medical imaging for its clients in India, USA, Middle East and Asia Pacific. Founded in 1997, today SoftLink has an impressive installed base of 175 plus clients in 15 countries, making it one of the fastest growing Healthcare IT MNC with Indian origin.
Recently, SoftLink released a .Net version of Panacea HIS, which is an instant hit with 3 major hospital in Pune and another international hospital in Zambia is deciding to implement it for their respective hospital. Panacea which is in its 5th release is a multi-centric and multi-branch HIS with a combination of client server, as well as Web base technology. The latest version, branded as 'Panacea.Net' has all good features of the original Panacea with added advantage of latest .Net technology.
Joshi Hospital, Ratna Memorial Hospital, as well as Poona Hospital and Research Center decided on Softlink HIS after uating HIS from number of vendors from different parts of India. Experience of more than decade in Hospital IT and an impressive product portfolio of SoftLink International comprising of a fully integrated suite of HIS/CIS/RIS/PACS, has helped them win these deals against competition. A “one-stop shop” for an end-to-end IT requirement in Hospital makes SoftLink a preferred vendor against competition.
ResMed introduces next-generation CPAP series in India
ResMed, a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment introduced its new cutting-edge sleep apnea therapy platform called the S9 Series in India.
The S9 Series combines a sleek design with superior functionality and more comfort. Combined climate control and humidification delivers unsurpassed comfort to the patient by controlling both the temperature and humidity that the patient breathes. The S9 Series is expected to not only help more sleep apnea patients adhere to the treatment, but also help sleep professionals make more informed decisions.
The most effective treatment for sleep apnea is Continuous Positive Airway Pressure (CPAP) therapy. In this non-invasive treatment, air is pressurised by a small device and delivered to the airway of the patient through a mask that fits on/over the nose, or nose and mouth. The pressurised air keeps the upper airway open and helps the person experience a restful night's sleep without interruptions caused by apneas.
The S9 Series is designed to deliver unsurpassed comfort to the patient by automatically controlling the pressure, temperature and humidity of the air that the patient breathes. The temperature as well as the humidity is controlled through input from five different sensors, including sensors close to the mask, a feature unique to the S9 Series over any of its competition. Optimal humidification is then achieved automatically. A new enhanced Easy-Breathe motor also reduces the conducted noise offering the quietest mask and machine combination available on the market.
S9 Features:
- Optional automatic climate control – this is a true paradigm shift in CPAP therapy.
- Easy-Breathe Technology for significantly reduced mask and machine noise levels (radiated and conducted).
- Enhanced Easy-Breathe EPR reduces the wo
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
Related News
Glenmark Pharmaceuticals Launches Vancomycin Hydrochloride Injection in the U.S.
Glenmark Pharmaceuticals Inc., USA has announced the launch of Vancomycin Hydrochloride for Injection USP in 500 mg/vial...
India’s MedTech Sector Poised to Reach $44 Billion by 2030
India’s medical technology sector is entering a transformative growth phase, with the industry p...
Roche Launches India’s First Subcutaneous Immunotherapy for Lung Cancer
Roche Pharma India has launched Tecentriq® SC (atezolizumab) in India, marking the country’s first subcutaneous immun...
MedVital Secures ₹18 Cr Funding to Expand Advanced Wound Care and Regenerative Aesthetics Portfolio
India’s medtech ecosystem continues to witness growing investor interest in clinically driven healthcare innovation, w...
NHM Madhya Pradesh Partners with Sanofi India to Expand NCD and Rare Disease Care
The National Health Mission Madhya Pradesh (NHM MP) has signed a Memorandum of Understanding (MoU) with Sanofi India to ...
IndiaAI–ICMR Partnership Signals India’s Push Toward a Sovereign, Responsible Healthcare AI Ecosystem
IndiaAI, flagship initiative of the Ministry of Electronics and Information Technology (MeitY), Government of India (GOI...
AngelSpark Backs Kubo Care to Scale AI-Led, Contactless Eldercare Monitoring Globally
Dubai-based angel investment collective AngelSpark has invested in healthtech startup Kubo Care, signalling rising inves...
Saudi Arabia-Based Metafare Secures $1M to Scale VR and AI-Driven Wellness
A new wave of immersive healthtech innovation is gaining traction in the Middle East, as Saudi Arabia-based startup Meta...
AIMS Director, Dr. M. Srinivas Appointed as NITI Aayog Member, Succeeds Dr. V. K. Paul
The Government of India has appointed Dr. M. Srinivas, Director of All India Institute of Medical Sciences, as a Member ...
$100 Million Life Sciences Campus to Come Up in Hyderabad, Boosting Genome Valley’s Global Standing
Hyderabad is set to strengthen its position as India’s life sciences hub with a major new investment, as Rx Propellant...
